These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 29759132)

  • 1. The Gamma-Aminobutyric Acid B Receptor in Depression and Reward.
    Jacobson LH; Vlachou S; Slattery DA; Li X; Cryan JF
    Biol Psychiatry; 2018 Jun; 83(11):963-976. PubMed ID: 29759132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Both GABA(B) receptor activation and blockade exacerbated anhedonic aspects of nicotine withdrawal in rats.
    Vlachou S; Paterson NE; Guery S; Kaupmann K; Froestl W; Banerjee D; Finn MG; Markou A
    Eur J Pharmacol; 2011 Mar; 655(1-3):52-8. PubMed ID: 21262222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of GABA
    Gawlińska K; Jastrzębska J; Gamberini S; Gawliński D; Pieniążek R; Suder A; Wydra K; Frankowska M
    Eur J Pharmacol; 2020 Sep; 883():173324. PubMed ID: 32621910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GABAB receptors in reward processes.
    Vlachou S; Markou A
    Adv Pharmacol; 2010; 58():315-71. PubMed ID: 20655488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GABAB receptors as a therapeutic strategy in substance use disorders: focus on positive allosteric modulators.
    Filip M; Frankowska M; Sadakierska-Chudy A; Suder A; Szumiec L; Mierzejewski P; Bienkowski P; Przegaliński E; Cryan JF
    Neuropharmacology; 2015 Jan; 88():36-47. PubMed ID: 24971600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GABAergic hypotheses of anxiety and depression: focus on GABA-B receptors.
    Pilc A; Nowak G
    Drugs Today (Barc); 2005 Nov; 41(11):755-66. PubMed ID: 16395415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicotine-induced molecular alterations are modulated by GABA
    Varani AP; Pedrón VT; Aon AJ; Höcht C; Acosta GB; Bettler B; Balerio GN
    Addict Biol; 2018 Jan; 23(1):230-246. PubMed ID: 28419642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeated administration of the GABAB receptor positive modulator BHF177 decreased nicotine self-administration, and acute administration decreased cue-induced reinstatement of nicotine seeking in rats.
    Vlachou S; Guery S; Froestl W; Banerjee D; Benedict J; Finn MG; Markou A
    Psychopharmacology (Berl); 2011 May; 215(1):117-28. PubMed ID: 21181127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The GABA
    Augier E; Dulman RS; Damadzic R; Pilling A; Hamilton JP; Heilig M
    Neuropsychopharmacology; 2017 Aug; 42(9):1789-1799. PubMed ID: 28294133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical potential of GABAB receptor modulators.
    Ong J; Kerr DI
    CNS Drug Rev; 2005; 11(3):317-34. PubMed ID: 16389296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blunted 5-HT
    Jacobson LH; Hoyer D; Fehlmann D; Bettler B; Kaupmann K; Cryan JF
    Psychopharmacology (Berl); 2017 May; 234(9-10):1511-1523. PubMed ID: 28070618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GABA
    Nieto A; Bailey T; Kaczanowska K; McDonald P
    Curr Top Behav Neurosci; 2022; 52():81-118. PubMed ID: 34036555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KK-92A, a novel GABA
    Li X; Sturchler E; Kaczanowska K; Cameron M; Finn MG; Griffin P; McDonald P; Markou A
    Psychopharmacology (Berl); 2017 May; 234(9-10):1633-1644. PubMed ID: 28382542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuation by baclofen of nicotine rewarding properties and nicotine withdrawal manifestations.
    Varani AP; Aso E; Moutinho LM; Maldonado R; Balerio GN
    Psychopharmacology (Berl); 2014 Aug; 231(15):3031-40. PubMed ID: 24553576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological characterization of GABAB receptor subtypes assembled with auxiliary KCTD subunits.
    Rajalu M; Fritzius T; Adelfinger L; Jacquier V; Besseyrias V; Gassmann M; Bettler B
    Neuropharmacology; 2015 Jan; 88():145-54. PubMed ID: 25196734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential of GABA
    Maccioni P; Colombo G
    CNS Drugs; 2019 Feb; 33(2):107-123. PubMed ID: 30604283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COR758, a negative allosteric modulator of GABA
    Porcu A; Mostallino R; Serra V; Melis M; Sogos V; Beggiato S; Ferraro L; Manetti F; Gianibbi B; Bettler B; Corelli F; Mugnaini C; Castelli MP
    Neuropharmacology; 2021 May; 189():108537. PubMed ID: 33798546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modelling depression in animals: at the interface of reward and stress pathways.
    Slattery DA; Cryan JF
    Psychopharmacology (Berl); 2017 May; 234(9-10):1451-1465. PubMed ID: 28224183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FRET-Based Sensors Unravel Activation and Allosteric Modulation of the GABA
    Lecat-Guillet N; Monnier C; Rovira X; Kniazeff J; Lamarque L; Zwier JM; Trinquet E; Pin JP; Rondard P
    Cell Chem Biol; 2017 Mar; 24(3):360-370. PubMed ID: 28286129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive modulation of GABA(B) receptors decreased nicotine self-administration and counteracted nicotine-induced enhancement of brain reward function in rats.
    Paterson NE; Vlachou S; Guery S; Kaupmann K; Froestl W; Markou A
    J Pharmacol Exp Ther; 2008 Jul; 326(1):306-14. PubMed ID: 18445779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.